Caregiver-Assisted Coping Skills Training for Lung Cancer: Results of a Randomized Clinical Trial by Porter, Laura S. et al.
Caregiver-Assisted Coping Skills Training for Lung Cancer:
Results of a Randomized Clinical Trial
Laura S. Porter, PhD, Francis J. Keefe, PhD, Jennifer Garst, MD, Donald H. Baucom, PhD,
Colleen McBride, PhD, Daphne C. McKee, PhD, Linda Sutton, MD, Kimberly Carson, MPH,
Verena Knowles, PhD, RN, Meredith Rumble, PhD, and Cindy Scipio, PhD
Duke University Medical Center (L.S.P., F.J.K., J.G., C.M., D.C.M., L.S., K.C., V.K., M.R., C.S.),
Durham; and University of North Carolina (D.H.B.), Chapel Hill, North Carolina, USA
Abstract
Context—Lung cancer is one of the most common cancers in the U.S. and is associated with
high levels of symptoms including pain, fatigue, shortness of breath, and psychological distress.
Caregivers as well as patients are adversely affected. However, previous studies of coping skills
training (CST) interventions have not been tested in patients with lung cancer nor systematically
included caregivers.
Objectives—This study tested the efficacy of a caregiver-assisted CST protocol in a sample of
patients with lung cancer.
Methods—Two hundred thirty-three lung cancer patients and their caregivers were randomly
assigned to receive 14 telephone-based sessions of either caregiver-assisted CST or education/
support involving the caregiver. Patients completed measures assessing pain, psychological
distress, QOL, and self-efficacy for symptom management; caregivers completed measures
assessing psychological distress, caregiver strain, and self-efficacy for helping the patient manage
symptoms.
Results—Patients in both treatment conditions showed improvements in pain, depression, QOL,
and self-efficacy and caregivers in both conditions showed improvements in anxiety and self-
efficacy from baseline to four-month follow-up. Results of exploratory analyses suggested that the
CST intervention was more beneficial to patients/caregivers with Stage II and III cancers, whereas
the education/support intervention was more beneficial to patients/caregivers with Stage I cancer.
Conclusion—Taken together with the broader literature in this area, results from this study
suggest that psychosocial interventions can lead to improvements in a range of outcomes for
cancer patients. Suggestions for future studies include the utilization of three-group designs (e.g.,
comparing two active interventions to a standard-care control) and examining mechanisms of
change.
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Introduction
Lung cancer is the second most common cancer in the United States and also the leading
cause of cancer deaths (1). Currently, about half of all lung cancer patients are diagnosed at
early stages (Stages I to III). Prognosis is generally poor, with five-year survival rates
ranging from 54% for Stage I disease to 10% for Stage III disease (1). Despite the relatively
poor prognosis, there are currently over 400,000 lung cancer survivors in the U.S. (1). These
patients and their caregivers face significant challenges of coping with symptoms such as
pain, fatigue, breathlessness, and psychological distress (2-4) which can persist for months
or years following treatment (5-7). In addition, patients with lung cancer report higher levels
of distress than patients with other types of cancer (8, 9).
Recent reviews and meta-analyses have supported the efficacy of psychosocial interventions
in helping cancer patients symptoms, and psychological distress (10-14). The terms
“psychological,” “psychosocial,” and “psychoeducational” have been used to refer to a
range of interventions including education, relaxation, guided imagery, music, hypnosis,
coping skills training, and supportive counseling (11, 13-15). While few studies have
directly compared different intervention strategies, some evidence from meta-analyses
suggests that coping skills training (CST) protocols based on cognitive-behavioral principles
are among the most effective (10, 14, 16). These interventions are explicitly designed to help
patients alter cancer-relevant thoughts, emotions, and behaviors through training in coping
skills such as relaxation, cognitive restructuring, and problem solving. Studies have shown
that, after completing CST interventions, patients report significant reductions in cancer
symptoms as well as improvements in QOL, psychological distress, self-efficacy, and
coping (10-14).
Despite the promise of CST interventions in helping cancer patients manage pain,
symptoms, and distress, to our knowledge no studies have tested the efficacy of these
interventions specifically in lung cancer patients. In addition, although there have been a
number of interventions directed at caregivers of cancer patients (17-19), there have been
few interventions to include both patients and caregivers together. There has been increasing
recognition of the impact of caregiving on family caregivers (17, 20-22) and a number of
interventions have been developed specifically for caregivers (17-19). The majority of these
interventions have focused on either providing caregivers with information (23, 24) or
psychological services such as supportive counseling (25) or problem-solving (26, 27).
However, few studies have involved both caregivers and patients together in CST
interventions. Doing so may be particularly beneficial for a number of reasons. First,
training both patient and caregiver in coping skills together may lead to enhanced
communication between the patient and caregiver regarding symptoms and symptom
distress, resulting in more efficacious treatment. Second, when caregivers learn coping skills
along with the patient they may be more likely to prompt and reinforce the patient’s use of
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learned skills, leading to enhanced effects for patients. A caregiver’s prompting and
reinforcement may be especially useful in helping the patient overcome obstacles to
applying coping skills such as a flare in breathlessness, pain symptoms, fatigue, or the onset
of a new symptom. Finally, involving caregivers coping skills training may enhance
caregivers’ confidence (i.e., self-efficacy) in their ability to help the patient cope with
symptoms, and help them manage their own distress.
The current study tested the efficacy of a new, caregiver-assisted CST protocol for patients
with early stage lung cancer. We hypothesized that, compared to an education/support
control condition, caregiver-assisted CST would lead to (a) improvements in patient
outcomes including symptoms, psychological distress, QOL, and self-efficacy for managing
symptoms; and (b) improvements in caregiver outcomes including caregiver strain,
psychological distress, and self-efficacy for helping the patient manage symptoms. We also
conducted exploratory analyses examining whether the intervention effects varied as a
function of cancer stage.
Methods
Participants and Setting
Participants were recruited from the Duke University Thoracic Oncology Program as well as
several community oncology clinics in the Durham, NC area between December 2002 and
March 2005. The entry criteria for patients included having (a) a diagnosis of early stage
lung cancer (non-small cell lung cancer Stages I-III, or limited stage small cell lung cancer),
(b) no other cancers in the past five years, (c) ability to read and speak English, and (d) a
caregiver who was also willing to participate. Patients were recruited at any point in the
illness trajectory, from the time of diagnosis through post-treatment. “Caregiver” was
broadly defined in this study as any friend or family member who provided practical and/or
emotional support to the patient. To identify the patient’s primary caregiver, the patient was
asked to list the people they relied on for support with things like getting to the doctor and
taking medication. They were then asked to review this list and identify the main person
they relied on for support. This person was identified as the primary caregiver and was
invited to participate in the study.
One thousand ninety-eight patients were screened for inclusion. Of these, 592 were deemed
ineligible and 506 were approached about participation. Of those approached, 201 (39.7%)
declined, 276 (54.5%) consented, and 29 (5.7%) were lost to contact. The most common
reasons for declining included lack of interest (42%), “too much trouble” (6%), and lack of
time (6%). Of the 276 who consented, 43 dropped out prior to completing baseline
questionnaires primarily because of death/declining health (47%), or loss of time or interest
(41%). This left a sample of 233 dyads that were included in the current analyses (Figure 1).
Procedures
All participants completed a pre-treatment evaluation and were then randomly assigned to
one of two conditions: (a) caregiver-assisted CST (n=117), or (b) cancer education/ support
including the caregiver (n=116). Randomization assignments were generated by an
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individual not involved in the study using a random number table. Assignments were
concealed in envelopes that were not opened until participants had completed their pre-
treatment evaluation. All participants completed a post-treatment assessment immediately
following completion of the treatment sessions and a four-month follow-up assessment. All
assessments were conducted over the telephone. Research assistants asked participants the
questions and recorded their answers on paper questionnaires. The research assistants
conducting the assessments were trained in standardized procedures for administration of
questionnaires using didactic instruction and role-plays of common scenarios. They were
kept blind to treatment condition. Medical information for the patients, including cancer
stage, treatments, and date of diagnosis, were extracted from the medical record. All patients
continued with their regular medical care and were followed by their oncologist in an
ongoing fashion. This care included medical and surgical treatments, as well as educational
information offered during clinic appointments and/or in form of written materials. All
procedures were approved by the Duke University Medical Center Institutional Review
Board and the Duke Comprehensive Cancer Center Protocol Review Committee.
Treatment Fidelity—Several steps were taken to ensure that the treatment protocols were
uniform and that the therapists followed the treatment protocols in a uniform manner. These
included therapist training, use of a detailed treatment outline, audiotaping of sessions,
weekly supervision of therapists, and assessments of treatment adherence and therapist
competence.
General Aspects of Treatment Procedures—Participants in both treatment
conditions (Caregiver-assisted CST and Education/Support) participated in 14 45-minute,
telephone-based sessions. Sessions were conducted via telephone rather than in person in
order to facilitate participation of dyads who lived at a distance from the medical center and
patients who were experiencing debilitating symptoms. All sessions were conducted with
individual patient-caregiver dyads (rather than in groups), and all participants were provided
with speaker phones to facilitate conducting the phone sessions simultaneously with both
members of the dyad. All sessions were audiotaped for purposes of supervision. The
sessions were scheduled over an eight-month period. The frequency of sessions was tapered
from weekly (sessions 1-3) to biweekly (sessions 4-10) to monthly (sessions 11-14) in order
to promote skill acquisition and application to symptoms that emerged over the course of the
illness trajectory.
Therapist Training—Both treatment conditions were delivered by registered nurses.
Nurses were trained by PhD-level psychologists (L.S.P., F.J.K., D.H.B, and D.C.M.,) and
medical oncologists (J.G. and L.S.) using didactic instruction, taped illustrations of
techniques from model cases, and role-play of common scenarios. Following the initial
training, nurses received ongoing weekly supervision with one of the psychologists who
reviewed audiotapes of the sessions and provided feedback regarding treatment quality and
adherence to the study protocol. Given the variability in factors such as the patient’s
symptom severity, types of treatments received, and time since diagnosis, particular
attention was given to helping therapists identify the specific needs of each dyad and apply
the information and skills training accordingly.
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Caregiver-Assisted Coping Skills Training
Participants in this condition received training in symptom management strategies. Sessions
were supplemented with written materials (e.g. handouts), provided to the participants in
advance of the sessions, that highlighted the major points discussed in the sessions and
detailed home practice assignments. Participants also received a CD (or audiotape) with
instructions for progressive muscle relaxation (written materials are available from the first
author upon request). The primary goals of the intervention were: (a) to teach the patients
and caregivers a variety of coping strategies that are effective in managing pain, fatigue,
shortness of breath, psychological distress, and other symptoms of lung cancer and its
treatment, and (b) to teach the caregiver how to help the patient acquire and maintain coping
skills over the illness trajectory. A summary of the coping skills included in the sessions is
presented in Table 2.
In the first session, the nurse introduced caregiver-assisted CST as a method to help
participants better manage the symptoms associated with lung cancer and its treatment. The
coping skills were described as methods that could help in managing the patient’s current
identified symptoms, as well as managing and minimizing the effects of other symptoms
that the patient may experience during the illness trajectory. The caregiver’s role was
described as that of “coach,” with the goal of helping the patient learn the coping skills and
apply them on a day-to-day basis. Caregivers were encouraged to learn and practice skills in
order to better assist the patient as well as to manage their own stress. In sessions 1-7, the
patient and caregiver were trained in specific coping skills including progressive muscle
relaxation training, a brief relaxation procedure (mini-practices), pleasant imagery, an
activity pacing method (activity-rest cycling), cognitive restructuring, strategies for problem
solving, goal setting and pleasant activity scheduling, and strategies for effective
communication of thoughts and feelings. In teaching each skill, the nurse used a three-step
behavioral rehearsal procedure in which instruction was provided in the skill, the dyad
practiced the skill together, and the nurse provided feedback to the dyad on their practice.
Each session started with a review of the patient’s and caregiver’s practice of the previous
sessions’ skills and ended with discussion of a home practice assignment. Sessions 8-12
focused on training in alternative versions of relaxation and imagery exercises, as well as
application of the coping skills to the particular challenges faced by the patient and/or
caregiver. In session 8, patients who had not yet quit smoking were also given the alternative
of discussing strategies for smoking cessation, including the caregiver’s role in helping the
patient in his/her attempts to quit. Session 11 was focused specifically on the caregiver,
encouraging the caregiver to explore his/her own resources and sources of stress and
discussing how to use coping skills to ease the burden of caregiving. (The patient
participated in this session as well.) Sessions 13 and 14 focused on maintenance strategies
including a review of the coping skills learned and how to maintain a regular practice of
skills in order to prevent and cope with possible setbacks.
Education/Support Condition
The primary goal of this intervention was to provide participants with information regarding
lung cancer and its treatment in a supportive environment in which patients and caregivers
were encouraged to discuss the patient’s treatment and symptoms. Caregivers were
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encouraged to participate fully in all discussions. Sessions were supplemented with handouts
summarizing the major points and listing additional resources (e.g., websites, books) that the
participants could access if they desired further information about a topic (again, written
materials are available from the first author upon request). Table 2 includes an overview of
the topics covered in the sessions. Participants in this condition did not receive any training
in coping skills.
The education/support sessions were delivered to participants using a presentation and
discussion format. Handouts and discussion sessions centered on presenting information on:
a. Description of lung cancer: information on the prevalence and incidence of the
disease; risk factors and etiology; forms of lung cancer; diagnostic procedures, and
symptomatology.
b. Treatment of lung cancer: goals of treatment were discussed including how staging
is done and how prognosis is determined. Information about various treatments
including surgery, chemotherapy, radiation therapy, medications, and alternative
types of treatment were discussed. Also included were the side effects of the
various treatment modalities and how these side effects are treated medically.
c. Understanding the physical aspects of lung cancer and how they are managed:
information about metastasis of the cancer, nutritional needs, physical comfort
measures, and medical approaches to pain and symptom management.
d. Palliative vs. curative care: information on palliative care and how palliative care
differs from curative treatment. Hospice care was discussed.
Measures
All evaluation measures were collected through a telephone interview. At each evaluation
session (baseline, post-test, and four-month follow-up), measures were collected from both
patient and caregiver.
Measures Collected from Patients
Pain: Pain was assessed using two items from the Brief Pain Inventory (BPI) (28) in which
participants rate their usual pain and their worst pain in the past week on a scale from 1 (“no
pain”) to 10 (“pain as bad as you can imagine”). The worst and usual BPI pain intensity
ratings have demonstrated good test-retest reliability (worst, r=0.93; usual, r=0.78) (29). The
validity of the BPI has also been supported by studies that have shown a significant
relationship between higher pain ratings and increased analgesic and narcotic use (29).
Psychological Distress: Psychological distress was assessed using the Beck Depression
Inventory (BDI) (30) and the trait anxiety version of the State Trait Anxiety Inventory
(STAI) (31). The BDI is a 21-item self-report inventory assessing current degree of
depression through items pertaining to affective, cognitive, motivational, and physiologic
areas of depressive symptomatology. The BDI has high internal consistency in clinical and
nonclinical populations, and good discriminant, construct, and concurrent validity (30). The
possible range on the BDI is from 0 to 63. Cronbach’s alpha in the current study was 0.86.
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The STAI was developed as a tool for investigating anxiety in normal (non-psychiatric)
adults, but has been used in assessing anxiety in neuropsychiatric, medical, and surgical
patients. The scale has demonstrated good psychometric properties (31). The possible range
on the STAI is from 20 to 80. Cronbach’s alpha in the current study was 0.92.
Quality of Life (QoL): QoL was measured using the Functional Assessment of Cancer
Therapy – Lung Cancer (FACT-L) (32). The FACT-L consists of four general and one lung
cancer symptom-specific subscale. The present study utilized three general subscales
(physical well-being, functional well-being, and social well-being) along with the lung
cancer specific subscale which includes items assessing shortness of breath, coughing,
weight loss, and loss of appetite. These subscales were chosen as they assess constructs that
are conceptually distinct from those assessed by the other measures used in this study (with
the exception of one item of the physical well-being subscale assessing pain). The FACT is
widely used in cancer studies and both the general measure and the lung cancer specific
measure have been shown to possess adequate psychometric properties (32, 33). The
possible range on each scale is from 0 to 28. Cronbach’s alphas in the present study were
0.85 (physical well-being), 0.86 (functional well-being), 0.70 (social well-being), and 0.73
(lung cancer symptoms).
Self-Efficacy: Self-efficacy for managing pain, symptoms, and function was assessed with a
modified version of a standard self-efficacy scale (34). The original scale was modified by
removing nine items relevant to patients with arthritis but not cancer, and adding seven
items regarding management of pain (from the Chronic Pain Self-Efficacy scale) (35) and
other common cancer symptoms such as shortness of breath. Patients rated 16 items
regarding their perceived ability to manage a variety of symptoms on a scale of 10 (not at all
certain) to 100 (completely certain). The scale contains three subscales: self-efficacy for
managing pain, self-efficacy for managing other symptoms (e.g., fatigue, nausea,
depression), and self-efficacy for function. Because the three subscales were highly
correlated with each other (r’s=0.71-0.86 for patients; 0.80-0.86 for caregivers), the total
score was utilized for this report (possible range=10-100). Prior studies using this instrument
to assess self-efficacy in cancer patients and their caregivers have demonstrated evidence of
its internal consistency and construct validity (36, 37). Cronbach’s alpha for the total scale
score was 0.95.
Measures Collected from Caregivers
Caregiver Mood: Caregiver mood was assessed using a brief version of the Profile of
Mood States-B (POMS-B(38)). Eighteen adjectives were used to rate average mood on
scales from 0=very much unlike this to 3=very much like this. These items were selected
from the larger number appearing on the POMS-B because of their high item-total
correlations for their respective subscales (39). The POMS-B has six subscales: tension/
anxiety (range 0-36), depression (range 0-60), anger/hostility (range 0-48), vigor/activity
(range 0-32), fatigue (range 0-28), and confusion/bewilderment (range 0-28). A total mood
disturbance scale is computed as a sum of all of the subscales (range 0-200). Cronbach’s
alpha for the total mood disturbance score was 0.89.
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Caregiver Strain: Caregiver strain was assessed with the Caregiver Strain Index (CSI) (40),
a 13-item scale that assesses a variety of stressors commonly experienced by caregivers. The
CSI has demonstrated high internal consistency (41) and construct validity (40). The
possible range on the CSI is from 0 to 13. In the current study, Cronbach’s alpha was 0.84.
Caregivers’ Self-Efficacy in Symptom Management: To assess caregivers’ confidence
regarding their ability to help the patient manage symptoms, a modified version of a
standard self-efficacy scale (34) was used. The caregiver version of the instrument is
identical to that used with patients except that caregivers are asked to rate how confident
they are that they can help the patient manage symptoms (e.g., “How certain are you that
you can help the patient decrease his/her pain quite a bit?,” “How certain are you that you
can do something to help the patient feel better if he/she is feeling blue?”). Cronbach’s alpha
for the total scale score was 0.96.
Statistical Analyses
Data were analyzed by intent-to-treat. Hierarchical linear modeling (HLM) (42) was used to
evaluate group differences over time. Each model estimated time, intervention (coping skills
training versus education/support), and time X intervention effects. The time effect assessed
whether the outcome changed across the baseline, post-test, and four-month follow-up
assessments. Significant effects of the intervention would be indicated by a significant time
X intervention effect.
In addition, we were interested in whether the effects of the interventions differed according
to the severity of the patient’s illness. Despite the fact that all patients in the study were
diagnosed with what is defined as “early stage” lung cancer, there was a great deal of
variability in the severity of their illness. For example, patients with Stage I cancers were
often asymptomatic at diagnosis, treated with surgery only, and told that their disease had
been cured. In contrast, patients with Stage II or III cancers were often quite ill at the time of
diagnosis, underwent multiple aggressive treatments including surgery, chemotherapy,
and/or radiation over a period of many months, and were given a much more guarded
prognosis. In order to determine whether patients with Stage I versus Stage II and III cancers
and their caregivers responded differently to the two interventions, we conducted
exploratory moderator analyses. These models estimated the effects of time, intervention,
cancer stage, time X intervention, time X cancer stage, intervention X cancer stage, and time
X intervention X cancer stage (Stage I versus Stage II-III). The three-way interaction (time
X intervention X cancer stage), if significant, would indicate that the effect of the
interventions over time varied according to the between patients with Stage I cancer (and
their caregivers) and those with Stage II-III cancer.
Examination of the distribution of the outcome variables indicated that a number of them
were skewed including the patient’s usual and worst pain, physical, social, and emotional
well-being, and depressive symptoms. These variables were log transformed, and analyses
were performed with the raw and log transformed values. The results of both sets of
analyses were identical, thus raw values were used in results reported below.
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Participant characteristics are presented in Table 1. Slightly more than half of the patients
(52.8%) were men, and the majority of caregivers (69%) were women. Both patients and
caregivers were predominantly Caucasian and well-educated. Seventy-six percent of the
caregivers were spouses of the patient, 14% were sons or daughters, and 8% were sisters,
brothers, and friends. In most cases (73%), the patients and caregivers lived in the same
household. There were no significant differences between patients and caregivers
randomized to the CST group and those randomized to education/support in demographic
variables (e.g., age, gender, race) or medical variables (e.g., days since diagnosis, receipt of
chemotherapy and radiation therapy, cancer stage).
Patient Outcomes
Analyses of patient outcome measures indicated significant main effects of time for ratings
of worst pain (B=−0.15, SE=0.13, P=0.02), physical well-being (B= 0.84, SE=0.22,
P=0.0002), functional well-being (B=0.55, SE=0.22, P=0.03), lung cancer symptoms
(B=0.76, SE=0.21, P=0.0003), depression (B=−0.55, SE=0.28, P=0.05), and self-efficacy
(B=2.31, SE=1.03, P=0.02). Patients in both CST and education/support reported
improvements over time in their worst pain ratings, their physical and functional well-being,
their lung cancer symptoms, their depressive symptoms, and their self-efficacy for
controlling symptoms. There were no significant time X intervention interactions.
Exploratory moderator analyses were conducted by dichotomizing patient’s cancer stage (I
vs. II and III) and including the three-way interaction term (time X intervention X cancer
stage) in the equations. The three-way interactions were significant for self-efficacy
(B=6.26, SE=3.20, P=0.05), depressive symptoms (B=−2.38, SE=0.86, P=0.006), trait
anxiety (B=−8.28, SE=2.85, P=0.005), and the functional well-being subscale of the FACT-
L (B=2.22, SE=0.80, P=0.006). These interactions were graphed according to the strategies
recommended by Preacher et al. (43). Similar patterns of findings were observed for all four
of the outcome variables (trait anxiety, depressive symptoms, self-efficacy, and functional
well-being). In each case, it appeared that patients with Stage I cancer benefited more from
the education/support intervention and patients with Stage II-III cancer benefited more from
CST intervention. The graph for trait anxiety is presented in Figure 2 as an example.
Caregiver Outcomes
Analyses of caregiver outcome measures indicated significant main effects of time for the
anxiety subscale of the POMS-B (B=−0.21, SE=0.21, P=0.02), and self efficacy (B=2.39,
SE=0.97, P=0.01). Caregivers in both CST and education/support reported decreases in
anxiety and increases in their self-efficacy for helping the patient manage symptoms. There
were no significant time X intervention interactions.
Moderator analyses were conducted by dichotomizing patient’s cancer stage (I vs. II and III)
and including the three-way interaction term (time X intervention X cancer stage) in the
equations. The three-way interactions were significant for caregiver strain (B=−0.99,
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SE=0.50, P=0.05) and self-efficacy (B=6.48, SE=3.03, P=0.03). These interactions were
graphed according to the strategies recommended by Preacher et al. (43). As with the patient
outcomes, the pattern of results for both caregiver strain and self-efficacy suggested that
caregivers of patients with Stage I cancer benefited more from the education/support
intervention while caregivers of patients with Stage II-III cancer benefited more from CST
intervention. The graph for self-efficacy is presented in Figure 3 as an example.
Discussion
To our knowledge, the current study is the first randomized clinical trial investigating the
efficacy of psychosocial interventions focused specifically on lung cancer patients. Lung
cancer is one of the most common yet understudied types of cancer and is associated with
particularly high levels of symptoms and distress, thus it is particularly important to develop
effective supportive care interventions for these patients (44). This study is also one of the
few rigorous tests of psychosocial protocols for cancer patients that systematically included
caregivers in the interventions and that compared two active interventions. The first,
caregiver-assisted CST, was based on cognitive-behavioral principles and taught patients a
variety of coping skills for managing their symptoms while teaching their partners how to
assist them in acquiring and maintaining these skills. The comparison condition was an
education/support intervention that provided patients and caregivers with educational
information about lung cancer and its management and as well as opportunities to ask
questions and discuss concerns related to the patient’s disease.
The main finding of this study was that both caregiver-assisted CST and the education/
support intervention were associated with improvements for lung cancer patients and their
caregivers. Patient improvements were seen in a variety of domains including their pain,
depression, physical well-being and lung cancer symptoms, their functional well-being, and
their self-efficacy for controlling symptoms. Caregivers reported increases in their self-
efficacy for helping the patients control symptoms and decreases in anxiety. Because this
study lacked a no treatment or standard care control condition, it is not possible to draw
definitive conclusions about the impact of these two interventions. It is possible that the
effects obtained could be due to time. This seems unlikely, however, given that recent
research has documented the severity and persistence of symptoms and psychological
distress experienced by lung cancer patients (2, 6, 7, 9, 44, 45).
The findings obtained in this study are consistent with previous studies that have found CST
interventions (10, 16) and educational interventions (10, 13, 14) effective in helping cancer
patients reduce symptoms and distress. To our knowledge, no previous studies have directly
compared CST and education/support interventions. In fact, the majority of previous studies
testing the effects of psychosocial interventions with cancer patients have not utilized any
active control condition (e.g., 46-52). The findings of the current study suggest that a
comprehensive caregiver-CST intervention produced similar results to an education/support
intervention involving the caregiver. This raises questions regarding the active ingredients of
the interventions (e.g., training in coping skills versus providing information), or whether
the improvements can be attributed to non-specific therapeutic effects (e.g., time and
attention). Ideally, future studies testing psychosocial interventions should utilize a three
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group design (e.g., CST versus education/support versus usual care) in order to better
answer these questions.
Another important question is which intervention works best for which patients and
caregivers. Because “early stage” lung cancer encompasses patients with a wide range of
illness severity, we examined in exploratory analyses whether the patient’s cancer stage
moderated the treatment effects. We found a pattern of results that suggested the caregiver-
assisted CST condition was most beneficial to patients with Stage II and III cancers and their
caregivers, whereas the education/support intervention was more beneficial to patients with
Stage I cancer and their caregivers. Among patients with Stage II and III cancers, those who
received caregiver-assisted CST were more likely to experience increases in self-efficacy
and physical function and decreases in depressive symptoms and anxiety than those who
received education/support. Caregiver-assisted CST also appeared to be helpful for
caregivers of patients with Stage II and III cancers as they showed increases in self-efficacy
and decreases in caregiver strain in response to this intervention. In contrast, patients with
Stage I cancers and their caregivers were more likely to demonstrate improvements in
response to the education/support intervention than to the caregiver-assisted CST
intervention.
There are several possible explanations for these differences in response. First, the
caregiver-assisted CST intervention may be much more salient to patients with Stage II and
III cancer and their caregivers as they are more likely to be experiencing disease-related
symptoms and may be more cognizant of the poor prognosis associated with the patient’s
disease. Second, because patients with Stage II and III cancers and their caregivers are
dealing with persistent symptoms, they have more opportunities to apply coping skills to
symptom management and to experience that these skills can actually help them control
symptoms. In contrast, patients with Stage I disease may be asymptomatic and feel quite
optimistic about their long-term prognosis. Because they and their caregivers are coping
with fewer treatment, symptoms, and stressors, they may be less likely to see the relevance
of learning and applying coping skills or to benefit from this approach. An education/
support intervention may be better matched to these patients and caregivers because it
provides them with helpful information in a supportive manner, but unlike caregiver-assisted
CST, places few demands on them to change their behavior or consider the possibility of
future cancer-related challenges. The type of detailed education provided in this intervention
may be beneficial to these individuals by alleviating concerns that come from lack of
understanding.
The results from this study suggest several potential avenues for future research. First, future
studies could examine the possibility that a stepped approach to intervention leads to the
greatest benefits for the greatest number of patients and caregivers. Second, future studies
could examine whether patients with early stage disease and their caregivers may benefit
from briefer interventions. Third, future studies could compare the efficacy of interventions
targeted to patient-caregiver dyads to those delivered to caregivers alone. Finally, future
studies should be designed to examine the mechanisms contributing to the efficacy of
various interventions. Developing a better understanding of the critical elements of
interventions and how they operate will enhance our ability to optimize therapeutic effects
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and translate intervention research into clinical practice (53). To date, few studies have
examined therapeutic processes in the context of psychosocial interventions for cancer
patients.
This study had several limitations. First, of those approached to participate, approximately
54% chose to do so. While this participation rate is lower than that reported in some
psychosocial intervention studies (46-48, 51, 52), it is somewhat higher than that obtained in
other studies which required the participation of a caregiver or spouse (range 34% (50, 54)
to 43% (49)). A second limitation of the study was the attrition rate (27% at post-test and
40% at four-month follow-up). However, most of the attrition in both arms was due to the
patient’s declining health or death. Interestingly, in prior studies researchers have noted
lower rates of retention for patients with lung cancer relative to patients with other types of
cancer (50), and lower rates of retention for lung cancer patients in the intervention versus
standard care (49). A third limitation was that this study was conducted with patients who
were primarily being seen in a tertiary care cancer center and who were predominantly
Caucasian. It is not clear that the results obtained are generalizable to patients seen in
community-based cancer treatment settings or those from other ethnic and cultural groups.
Finally, patients in this study varied in their stage in the illness trajectory. Future studies
should evaluate the optimal timing of CST and educational interventions (e.g., shortly after
diagnosis, during active treatment, or following treatment in the survivorship phase).
This study adds to the existing literature on psychosocial interventions for cancer patients by
its focus on patients with lung cancer. It is notable for the systematic inclusion of caregivers
in the interventions, and for the comparison of two active treatment conditions. Results
suggest that the interventions may have led to improvements in psychological distress,
symptoms, and self-efficacy, although it is also possible these changes were due to time.
Given the wide range of psychosocial interventions for cancer patients that have been tested
and the few studies that have compared two active interventions, little is known about which
interventions are most effective. There has also been little research examining therapeutic
processes which would shed light on how interventions produce change. The next wave of
studies in this field should strongly consider utilizing three-group designs (e.g., comparing
two active interventions to a standard-care control) and planning for analyses of mechanisms
of change. This will lead to significant contributions to the knowledge base as well as
providing information that can be used more readily to enhance the clinical care of patients
with cancer and their loved ones (53).
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Estimated trajectories of change in the patients’ scores on the trait version of the State Trait
Anxiety Inventory by treatment condition and lung cancer stage.
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Estimated trajectories of change in the caregivers’ scores on the self-efficacy scale by
treatment condition and the patient’s lung cancer stage.
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Mean age (SD) 65.3 (9.5) 59.3 (12.3)
Gender (% male) 52.8 31.0
Race
 Caucasian 84.5% 82.0%
 African American 11.6% 11.2%
 Other/unknown 3.9% 6.4%
Education
 <12 years 14.2% 8.2%
 High school graduate 30.9% 32.3%
 Some college 29.6% 30.2%
 College graduate 16.3% 13.8%
 Post-graduate 9.0% 15.5%
Median days since diagnosis (IQR) a 207.5 (668)
 25th percentile 105






 Non-small cell Stage I n=122 (52.6%)
 Non-small cell Stage II n=37 (15.9%)
 Non-small cell Stage III n=60 (25.9%)
 Small cell limited stage N=10 (4.3%)
IQR = interquartile range.
a
Date of diagnosis was not available for three patients.
b
Staging information was not available for four patients.
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Table 2
Summary of Topics Covered in Each Treatment Condition
Coping Skills Training Education/Support








• Smoking cessation (optional)
• Maintenance enhancement strategies
• Basic information on lung cancer (e.g., prevalence, risk factors)
• Treatment of lung cancer (including surgery, chemotherapy, radiation therapy,
medications, and common treatment side effects)
• Nutritional needs
• Physical comfort measures
• Medical approaches to pain and symptom management
• Palliative care
• Hospice care
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